Who is sponsoring NCT02935621?

NCT02935621 is sponsored by University of Utah.

What drugs are being tested in NCT02935621?

Interventions in NCT02935621: Mindfulness-Oriented Recovery Enhancement (MORE), Support Group.

What condition does NCT02935621 study?

NCT02935621 studies Chronic Pain.

Is NCT02935621 still recruiting?

NCT02935621 is currently completed. Last updated 22 March 2023.

Last reviewed 2023-03-22 · How we verify

NCT02935621

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Behavioral Interventions for Active Duty Service Members and Veterans With Chronic Pain

Completed NA Last updated 22 March 2023

What this trial tests

NA trial testing Mindfulness-Oriented Recovery Enhancement (MORE) in Chronic Pain in 230 participants. Completed in 15 December 2022.

Timeline

1 April 2017

Primary endpoint
15 December 2022

15 December 2022

Quick facts

Lead sponsor	University of Utah
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	230
Start date	1 April 2017
Primary completion	15 December 2022
Estimated completion	15 December 2022
Sites	1 location across United States

Drugs / interventions tested

Mindfulness-Oriented Recovery Enhancement (MORE)
Support Group

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

University of Utah

Who can join

Adults 18 to 100, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The central aim of this proposed study is to test a multimodal, mindfulness-oriented intervention designed to disrupt the risk chain leading to prescription opioid dose escalation, opioid misuse and opioid addiction, which are mounting threats to active duty service members and Veterans with chronic pain conditions, who may develop disordered opioid use as a consequence of long-term opioid pharmacotherapy.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions for the reduction of prescribed opioid use in chronic non-cancer pain.
Eccleston C, Fisher E, Thomas KH, Hearn L, et al · · 2017 · cited 88× · PMID 29130474 · DOI 10.1002/14651858.cd010323.pub3
Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial.
Garland EL, Nakamura Y, Bryan CJ, Hanley AW, et al · · 2024 · cited 28× · PMID 38196335 · DOI 10.1176/appi.ajp.20230272
Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards.
Garland EL, Fix ST, Hudak JP, Bernat EM, et al · · 2023 · cited 28× · PMID 37310337 · DOI 10.1017/s0033291721003834
Endogenous theta stimulation during meditation predicts reduced opioid dosing following treatment with Mindfulness-Oriented Recovery Enhancement.
Hudak J, Hanley AW, Marchand WR, Nakamura Y, et al · · 2021 · cited 23× · PMID 32919401 · DOI 10.1038/s41386-020-00831-4
Cochrane in CORR®: Interventions for the Reduction of Prescribed Opioid Use in Chronic Non-cancer Pain.
Madden K, Bhandari M. · · 2018 · cited 1× · PMID 29601400 · DOI 10.1007/s11999.0000000000000288

Verify or expand the search:

Other trials of Mindfulness-Oriented Recovery Enhancement (MORE)

Trials testing the same drug.

NCT03948893 — Smoking Cessation Behavioral Treatment Study · NA · recruiting

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other University of Utah trials

Trials by the same sponsor.

NCT07515755 — Supplemental Oxygen and Oxygen Desaturations in Colonoscopies · NA · not yet recruiting
NCT07225426 — Personalizing Financial Incentives · NA · recruiting
NCT06716411 — Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness · NA · recruiting
NCT07246538 — Positive Airway Pressure (PAP) System Evaluation in Volunteers · NA · not yet recruiting
NCT04208984 — Diversion Device With Breath Control · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02935621 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Utah
Last refreshed: 22 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02935621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing